Has Jordan Dickens received payments from drug or device companies?

Yes. Drug and device makers reported $6,478 in general payments to Jordan Dickens across 237 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jordan Dickens did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jordan Dickens come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jordan Dickens

Psychiatric/Mental Health · Houston, TXNPI 1831818822

Payments from drug & device makers

$6,478in general payments, 2019–2025

Across 237 payments — averaging $27.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$1K
Teva Pharmaceuticals USA, Inc.$1K
Neurocrine Biosciences, Inc.$858
Otsuka America Pharmaceutical, Inc.$685
AbbVie$554
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$487
plus $2K from 11 others

What the payments were for

Food & beverage$6,472100%
Education$50%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	35	$1,235
Teva Pharmaceuticals USA, Inc.	35	$1,075
Neurocrine Biosciences, Inc.	25	$858
Otsuka America Pharmaceutical, Inc.	33	$685
AbbVie	31	$554
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	14	$487
Lundbeck LLC	20	$339
Axsome Therapeutics, Inc.	11	$284
Alkermes, Inc.	8	$254
Vanda Pharmaceuticals Inc.	8	$250
Corium, LLC	5	$193
E.r. Squibb & Sons, L.L.C.	4	$109
Supernus Pharmaceuticals, Inc.	3	$70
Tempus AI, Inc	2	$28
Livanova USA, Inc.	1	$22
Idorsia Pharmaceuticals US Inc	1	$19
Almatica Pharma LLC	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,478 in reported general payments places this provider in the 90th percentile of 2,724 psychiatric/mental health providers in Texas.

See all psychiatric/mental health providers in Texas →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydroxyzine Hcl	30	$327
Quetiapine Fumarate	44	$322
Bupropion XlBupropion Hcl	21	$207
Lamotrigine	27	$183
Trazodone Hcl	15	$92
Clonazepam	23	$82
Escitalopram Oxalate	12	$23
Fluoxetine Hcl	15	$16

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Houston

Natalie TellezHouston$602K
Britney PridgenHouston$57K
Linzi LeightonHouston$16K
Samantha SharpeHouston$14K
Jennifer RobinsonHouston$12K
Tracy HicksLongview$684K
Karah BrashierRichardson$567K
Grant DavisRichardson$360K
Victor IlogEl Paso$167K
Lisa ShamblinGrapevine$163K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →